Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02289560 · ClinicalTrials.gov registry record · NA
Continued Access Protocol: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors
A NA study, sponsored by InSightec.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT02289560 is a NA study that has completed, run by InSightec. The registered enrollment target is 61 participants.
The verdict
NCT02289560, a NA study, has completed, sponsored by InSightec.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The objective of this prospective, multi site, single-arm study is to capture the efficacy of treatment using the ExAblate Transcranial System and to further demonstrate safety in medication-refractory tremor in patients with essential tremor (ET).
Interventions
- DEVICE Transcranial ExAblate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2015-04 |
| Est. Completion | 2023-03-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02289560
The ClinicalTrials.gov registry entry for NCT02289560 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InSightec, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial ExAblate is the first listed.
NCT02289560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02289560 about?
NCT02289560 is a clinical study titled "Continued Access Protocol: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors". The objective of this prospective, multi site, single-arm study is to capture the efficacy of treatment using the ExAblate Transcranial System and to further demonstrate safety in medication-refractory tremor in patients with essential tremor (ET).
What is the current status of trial NCT02289560?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2015-04. Estimated completion is 2023-03-10.
What interventions are being tested in trial NCT02289560?
The interventions under investigation include: Transcranial ExAblate (DEVICE).
Who is sponsoring clinical trial NCT02289560?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.